⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Acurion Health and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Acurion Health
↗San Diego, USA
Acurion Health is a precision oncology technology company that develops AI-powered digital pathology tools. Its flagship platform, OncoGaze™, analyzes routine histopathology slides to identify molecular biomarkers, such as homologous recombination deficiency (HRD), without requiring additional tissue or specialized molecular testing.
The company aims to expand access to precision medicine by enabling oncologists to derive clinically actionable insights from standard diagnostic images. By integrating AI into existing clinical workflows, Acurion seeks to reduce diagnostic delays and facilitate faster, more personalized treatment decisions for cancer patients.
CLASSIFICATION
Company Type:Digital Health
Therapeutic Areas:
Industry:Digital Health
Sub-Industry:Precision Oncology / AI Diagnostics
SIZE & FINANCIALS
Employees:1-50
Founded:2021
Ownership:private
Status:operating
FUNDING
Stage:Seed
Total Raised:$4.3M
Investors:TK & Partners
PIPELINE
Stage:Commercial
Lead Drug Stage:N/A (Diagnostic Platform)
Modalities:AI Diagnostics
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:Pancreatic Cancer Action Network (PanCAN) - Partnership to accelerate pancreatic cancer diagnostics using AI and real-world patient data.
COMPETITION
Position:Emerging
LEADERSHIP
Key Executives:
Magda Marquet, Ph.D. - Co-Founder and Board Member
Board Members:Magda Marquet, Ph.D.
LINKS
Website:acurionhealth.com
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Acurion Health. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.